Crespi Bernard J
Department of Biosciences, Simon Fraser University Burnaby, BC, Canada.
Evol Appl. 2011 Mar;4(2):292-314. doi: 10.1111/j.1752-4571.2010.00156.x. Epub 2010 Oct 12.
In this review, I describe how evolutionary genomics is uniquely suited to spearhead advances in understanding human disease risk, owing to the privileged position of genes as fundamental causes of phenotypic variation, and the ability of population genetic and phylogenetic methods to robustly infer processes of natural selection, drift, and mutation from genetic variation at the levels of family, population, species, and clade. I first provide an overview of models for the origins and maintenance of genetically based disease risk in humans. I then discuss how analyses of genetic disease risk can be dovetailed with studies of positive and balancing selection, to evaluate the degree to which the 'genes that make us human' also represent the genes that mediate risk of polygenic disease. Finally, I present four basic principles for the nascent field of human evolutionary medical genomics, each of which represents a process that is nonintuitive from a proximate perspective. Joint consideration of these principles compels novel forms of interdisciplinary analyses, most notably studies that (i) analyze tradeoffs at the level of molecular genetics, and (ii) identify genetic variants that are derived in the human lineage or in specific populations, and then compare individuals with derived versus ancestral alleles.
在这篇综述中,我阐述了进化基因组学如何特别适合引领在理解人类疾病风险方面取得进展,这是因为基因作为表型变异的根本原因具有特殊地位,以及群体遗传学和系统发育方法能够从家族、群体、物种和进化枝层面的遗传变异中有力地推断自然选择、遗传漂变和突变过程。我首先概述了人类基于遗传的疾病风险的起源和维持模型。然后,我讨论了如何将遗传疾病风险分析与正选择和平衡选择研究相结合,以评估“造就我们人类的基因”在多大程度上也代表了介导多基因疾病风险的基因。最后,我提出了人类进化医学基因组学这个新兴领域的四条基本原则,每一条原则从直接的角度来看都代表着一个非直观的过程。对这些原则的综合考虑促使进行新形式的跨学科分析,最显著的是(i)在分子遗传学层面分析权衡的研究,以及(ii)识别在人类谱系或特定群体中衍生的遗传变异,然后比较具有衍生等位基因与祖先等位基因的个体的研究。